CPN-219
CPN-219, a next-generation hexapeptidic NMUR2 agonist, achieves a dose-dependent and selective activation of NMUR2 with an EC50 value of 2.2 nM[1].
Product Specifications
CAS Number
2240202-02-0
UNSPSC
12352209
Target
Neuromedin U Receptor (NMUR)
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cpn-219.html
Purity
99.08
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCN)C(N1[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(N)=O)=O)=O)CCC1)=O)=O)=O)CCC2CCCCC2
Molecular Formula
C40H72N12O8
Molecular Weight
849.08
References & Citations
[1]Kentaro Takayama, et al. A chemically stable peptide agonist to neuromedin U receptor type 2. Bioorg Med Chem. 2020 May 15;28 (10) :115454.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
NMUR2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CCNB1IP1 (E3 Ubiquitin-protein Ligase CCNB1IP1, Cyclin-B1-interacting Protein 1, Human Enhancer of Invasion 10, C14orf18, HEI10) APC
CCNB1IP1 (E3 Ubiquitin-protein Ligase CCNB1IP1, Cyclin-B1-interacting Protein 1, Human Enhancer of Invasion 10, C14orf18, HEI10) APC
Recombinant Human Putative cyclin-Y-like protein 3 (CCNYL3)